Aurinia Pharmaceuticals
AUPH
#5392
Rank
NZ$1.94 B
Marketcap
$14.19
Share price
5.30%
Change (1 day)
47.89%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): -NZ$24.72 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.22 Billion. In 2023 the company made an earning of -NZ$0.14 Billion, an increase over its 2022 earnings that were of -NZ$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$24.72 Million-81.47%
2023 -NZ$0.14 Billion-31.8%
2022 -NZ$0.2 Billion-39.4%
2021 -NZ$0.33 Billion61.9%
2020 -NZ$0.2 Billion-9.73%
2019 -NZ$0.23 Billion92.65%
2018 -NZ$0.12 Billion36.39%
2017 -NZ$84.02 Million106.29%
2016 -NZ$40.73 Million-15.4%
2015 -NZ$48.14 Million65.84%
2014 -NZ$29.03 Million129.82%
2013 -NZ$12.63 Million-26.6%
2012 -NZ$17.21 Million
2010 -NZ$9.75 Million-39.22%
2009 -NZ$16.03 Million-43.78%
2008 -NZ$28.52 Million-53.19%
2007 -NZ$60.92 Million42.97%
2006 -NZ$42.61 Million-23.03%
2005 -NZ$55.36 Million36.1%
2004 -NZ$40.68 Million172.57%
2003 -NZ$14.93 Million484.61%
2002 -NZ$2.56 Million
2000 -NZ$12.13 Million453.81%
1999 -NZ$2.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$8.53 B-31,667.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$9.79 Million-63.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$39.49 Million 46.09%๐Ÿ‡บ๐Ÿ‡ธ USA